Free Trial
→ A new income category is drawing serious money - here's why (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$175.54
+0.9%		$158.46
$108.35
▼
$177.05
$49.06B1.212.55 million shs1.89 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$267.93
-1.4%		$233.03
$93.50
▼
$309.35
$41.04B1.414.41 million shs2.99 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$628.60
+1.9%		$605.85
$373.00
▼
$677.90
$17.21B1.18259,226 shs391,767 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$695.75
+3.3%		$635.37
$435.27
▼
$704.00
$248.91B0.872.34 million shs3.96 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+0.95%+4.44%+16.73%+33.65%+26.16%
Illumina, Inc. stock logo
ILMN
Illumina
-1.41%+1.27%+20.53%+43.55%+188.10%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+1.94%+4.30%+1.31%+16.90%+22.22%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
+3.20%+6.77%+8.56%+30.74%+31.94%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$175.54
+0.9%		$158.46
$108.35
▼
$177.05
$49.06B1.212.55 million shs1.89 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$267.93
-1.4%		$233.03
$93.50
▼
$309.35
$41.04B1.414.41 million shs2.99 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$628.60
+1.9%		$605.85
$373.00
▼
$677.90
$17.21B1.18259,226 shs391,767 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$695.75
+3.3%		$635.37
$435.27
▼
$704.00
$248.91B0.872.34 million shs3.96 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+0.95%+4.44%+16.73%+33.65%+26.16%
Illumina, Inc. stock logo
ILMN
Illumina
-1.41%+1.27%+20.53%+43.55%+188.10%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+1.94%+4.30%+1.31%+16.90%+22.22%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
+3.20%+6.77%+8.56%+30.74%+31.94%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.79
Moderate Buy$173.65-1.08% Downside
Illumina, Inc. stock logo
ILMN
Illumina
2.44
Hold$225.94-15.67% Downside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.23
Hold$607.73-3.32% Downside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.81
Moderate Buy$654.05-5.99% Downside

Current Analyst Ratings Breakdown

Latest TMO, ILMN, MEDP, and A Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/15/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$740.00
10/15/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageBuy
10/15/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$740.00
10/13/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$675.00 ➝ $760.00
10/13/2026
Illumina, Inc. stock logo
ILMN
Illumina
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetHold$210.00 ➝ $270.00
10/13/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$175.00 ➝ $190.00
10/13/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$180.00 ➝ $196.00
10/12/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$650.00 ➝ $730.00
10/8/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C+) ➝ Buy (B-)
10/8/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeBuy (B-) ➝ Buy (B)
10/8/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C+) ➝ Buy (B-)
(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B7.12$6.69 per share26.24$23.78 per share7.38
Illumina, Inc. stock logo
ILMN
Illumina
$4.34B9.32$6.62 per share40.47$17.82 per share15.04
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.93$17.35 per share36.24$16.30 per share38.56
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$46.34B5.55$31.42 per share22.14$142.17 per share4.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$5.0834.5625.822.6519.53%24.45%13.09%11/23/2026 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
$850M$5.3649.9943.783.8518.36%29.84%12.17%10/29/2026 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$17.0636.1532.792.7517.67%110.15%24.84%10/21/2026 (Confirmed)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.70B$18.5937.4325.272.8115.04%17.09%8.12%10/21/2026 (Estimated)

Latest TMO, ILMN, MEDP, and A Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Illumina, Inc. stock logo
ILMN
Illumina
$1.36N/AN/AN/A$1.15 billionN/A
10/21/2026Q3 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$4.44N/AN/AN/A$714.47 millionN/A
10/21/2026Q3 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.40N/AN/AN/A$11.95 billionN/A
8/26/2026Q3 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.49$1.62+$0.13$1.28$1.84 billion$1.88 billion
7/30/2026Q2 2026
Illumina, Inc. stock logo
ILMN
Illumina
$1.23$1.31+$0.08$1.35$1.13 billion$1.16 billion
7/23/2026Q2 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.71$6.03+$0.32$4.68$11.71 billion$11.99 billion
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98$4.25+$0.27$4.25$689.51 million$707.33 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.58%+6.58%20.08%9 Years
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.880.27%+14.34%10.11%8 Years

Latest TMO, ILMN, MEDP, and A Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/16/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.25500.6%10/6/202610/6/202610/28/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.50
2.05
1.56
Illumina, Inc. stock logo
ILMN
Illumina
0.53
1.80
1.40
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.74
1.55
1.18

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
2.90%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100281.93 millionN/AOptionable
Illumina, Inc. stock logo
ILMN
Illumina
8,650151.00 million146.62 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20027.91 million22.19 millionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000369.75 million368.53 millionOptionable

Recent News About These Companies

Thermo Fisher Scientific stock pre-market at EUR 621.70
 |  ad-hoc-news.deA
Thermo Fisher Scientific Reaches $696: What the 52-Week High Signals
 |  247wallst.comhttps://247wallst.com/cards/thermo-fisher-just-set-a-52-week-high-at-696-49-roughly-56-tmo-price-extreme-01m50zdggf1257vg8zavstvzcw
Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/immuno-oncology-diagnostics-market-reach-094300229.html
AI Is Speeding Up Drug Discovery, but FDA Trial Phases Still Decide Which Biotech Stocks Win
Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built (TMO)
...
October 15 at 5:44 PM  |  marketbeat.comhttps://www.marketbeat.com/articles/quantum-biopharmas-phase-2-shows-where-biotech-value-actually-gets-built/
Thermo Fisher Scientific (NYSE:TMO) Reaches New 52-Week High - Here's Why
October 15 at 10:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-thermo-fisher-scientific-nyse-tmo-reaches-new-52-week-high-heres-why-2026-10-15/
FY2027 Earnings Estimate for TMO Issued By Erste Group Bank
October 15 at 1:59 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31120596
Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth
October 14 at 11:47 AM  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermo-fisher-scientific-tmo-reports-130013405.html
Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth
October 14 at 11:01 AM  |  zacks.comhttps://www.zacks.com/stock/news/3007029/thermo-fisher-scientific-tmo-reports-next-week-wall-street-expects-earnings-growth?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_9-3007029
How to Invest in AI Drug Discovery
October 14 at 7:58 AM  |  etftrends.comE
Global 3D Cell Culture Technologies Market Report 2026-2030 | Capitalize on 19.9% CAGR as Merck KGaA, Corning, Thermo Fisher Scientific, Sartorius, and Lonza Scale Organoids
October 14 at 6:46 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/global-3d-cell-culture-technologies-080700696.html
Single-Use Assemblies Global Market Report 2026-2030 | Capitalize on 22.8% CAGR as Thermo Fisher, Danaher, Sartorius, Merck, and Avantor Scale Modular Bioprocessing
October 14 at 6:46 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/single-assemblies-global-market-report-080900706.html
Thermo Fisher Scientific Inc. (TMO) - What Are Analysts Thinking About This Stock?
October 14 at 2:59 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31117629
Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Has Consensus Price Target of $642.33 According to Brokerages
October 14 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-thermo-fisher-scientific-inc-nyse-tmo-stock-has-consensus-price-target-of-64233-according-to-brokerages-2026-10-14/
Thermo Fisher Scientific (TMO) Set to Release Earnings on Wednesday
October 14 at 2:26 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31117469
Thermo Fisher Scientific (TMO) Projected to Post Quarterly Earnings on Wednesday
October 14 at 2:26 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/upcoming-thermo-fisher-scientific-tmo-projected-to-post-quarterly-earnings-on-wednesday-2026-10-14/
Thermo Fisher’s Expanded Drug Lifecycle Role Might Change The Case For Investing In Thermo Fisher Scientific (TMO)
October 13 at 12:38 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/thermo-fisher-expanded-drug-lifecycle-121613217.html
Thermo Fisher to Report Q3 Earnings: What's in the Cards?
October 13 at 12:38 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/thermo-fisher-report-q3-earnings-132500188.html
Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth
October 13 at 12:38 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/biotech-pharma-rebound-strengthen-thermo-135425420.html
Thermo Fisher to Report Q3 Earnings: What's in the Cards?
October 13 at 11:25 AM  |  zacks.comhttps://www.zacks.com/commentary/3005760/thermo-fisher-to-report-q3-earnings-what-s-in-the-cards?cid=cs-stocknewsapi-ft-earnings_preview-3005760
Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth
October 13 at 11:11 AM  |  insidermonkey.comhttps://www.insidermonkey.com/news/biotech-and-pharma-rebound-strengthen-thermos-tmo-organic-growth-1853744/
Erste Group Bank Has Strong Outlook for TMO FY2027 Earnings
October 13 at 8:26 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-erste-group-bank-has-strong-outlook-for-tmo-fy2027-earnings-2026-10-13/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Close-up of an Nvidia logo on a computer chip mounted on a circuit board with cables and hardware components.
NVIDIA Just Strengthened the Case for Its Massive Stock Price Upside
By Thomas Hughes | September 29, 2026
Laptop displaying the Hims & Hers logo beside a gavel, pill bottle, and declining stock chart with the US Capitol.
Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
By Jessica Mitacek | September 24, 2026
NVIDIA logo illuminated on a wall in a server data center, with a graphics card in the foreground.
AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
By Thomas Hughes | September 16, 2026
Glass-walled office building lobby at sunset with a city skyline reflected in the exterior facade.
Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes
By Chris Markoch | September 27, 2026
Digital illustration of a central computer chip connected by glowing blue and green lines to server nodes over a world map.
These 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity Push
By Thomas Hughes | September 20, 2026
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$175.54 +1.54 (+0.89%)
Closing price 10/15/2026 03:59 PM Eastern
Extended Trading
$175.36 -0.19 (-0.11%)
As of 08:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Illumina stock logo

Illumina NASDAQ:ILMN

$267.93 -3.83 (-1.41%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$269.19 +1.26 (+0.47%)
As of 08:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Medpace stock logo

Medpace NASDAQ:MEDP

$628.60 +11.97 (+1.94%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$633.03 +4.43 (+0.71%)
As of 08:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$695.75 +22.55 (+3.35%)
Closing price 10/15/2026 03:59 PM Eastern
Extended Trading
$698.24 +2.49 (+0.36%)
As of 08:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas